Boothbay Fund Management, LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$0.6 - $2.31 $6,000 - $23,100	-10,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.63 - $2.27 $6,300 - $22,700	10,000 New	10,000 $23,000
Q4 2018 Feb 14, 2019	SELL	$0.53 - $1.11 $22,525 - $47,175	-42,500 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$0.35 - $0.92 $14,874 - $39,100	42,500 New	42,500 $39,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.